Synopsis: TruAlt Bioenergy (28% float), Solarworld (13%), Sudeep Pharma, Omnitech unlock shares today. Pre-IPO investors can sell; TruAlt faces biggest pressure with ₹403 stock vs ₹496 IPO price.
A wave of IPO lock-in expiries hits the market today. Four stocks TruAlt Bioenergy, Sudeep Pharma, Solarworld Energy Solutions, and Omnitech Engineering see restricted shares become available for trading. The biggest one to watch is TruAlt Bioenergy. A whopping 28% of its total shares unlock today. That is enough to rattle prices and unsettle investors.
Lock-in periods are SEBI-mandated restrictions. They stop pre-IPO investors from selling shares immediately after listing. Once the period ends, those investors are free to sell. When a large chunk unlocks at once, markets tend to get nervous and for good reason.
What Is a Lock-In Period and Why Does It Matter?
When a company lists on the stock exchange, early investors founders, pre-IPO backers, and anchor investors must hold their shares for a fixed period. SEBI sets this rule to prevent a sudden sell-off right after listing. The lock-in period is typically one to six months, depending on the investor category.
Today, all four companies hit their expiry dates together. The shares were locked in from around late September 2025 and are now eligible for trading. However, not all unlocked shares will flood the market at once. It depends on whether holders actually choose to sell.
TruAlt Bioenergy and Solarworld: The High-Risk Pair
TruAlt Bioenergy faces the most scrutiny today. Its 23.6 million shares representing 28% of total outstanding stock are now free to trade. The stock currently sits around ₹403–415, below its IPO price of ₹496. That means pre-IPO investors may already be sitting on paper losses or thin margins.
The company itself has strong numbers. Revenue in FY25 jumped 54% year-on-year to ₹1,968 crore. Net profit surged 361% to ₹146 crore. It operates five distilleries in Karnataka and holds about 3.6% of India’s ethanol market. Nevertheless, promoters have pledged nearly 37% of their shareholding, adding governance concerns on top of the unlock pressure.
Solarworld Energy Solutions is the second name to watch. Around 11.6 million shares, or 13% of total stock, unlock today. The stock has already fallen sharply from an IPO price of ₹351 to roughly ₹143 now. A 13% unlock on a stock already under pressure could push it further down if pre-IPO holders choose to exit. Solarworld builds solar projects for commercial and industrial clients. Its FY25 revenue was ₹551 crore, up 9% year-on-year, with net profit rising 49% to ₹77 crore.
Sudeep Pharma and Omnitech: A Different Picture
Not every unlock today spells trouble. Sudeep Pharma‘s expiry is almost a non-event. Only 0.2 million shares less than 0.2% of total stock are coming off lock-in. The stock trades near or above its IPO price of ₹593, and it has already absorbed earlier anchor expiries without much damage. Its FY25 revenue stood at ₹502 crore with a net profit of ₹139 crore. Given the tiny size of today’s unlock, market impact is expected to be minimal.
Omnitech Engineering, a precision parts maker based in Gujarat, sees 3.8 million shares unlock today. That is 3% of its total shares and relates to the anchor investor 30-day lock-in portion. The stock listed in early March 2026 at a discount, around ₹202–205, but has since recovered to roughly ₹245. An anchor unlock of this size typically creates short-term pressure of 5–15%, but the limited size reduces the risk of a larger move.
What Should Investors Watch Now?
Therefore, today’s expiries do not all carry equal weight. TruAlt’s 28% unlock is the one that could move markets meaningfully. Investors should watch for block deals, large sell orders, or any promoter disclosures filed with BSE or NSE.
Meanwhile, Solarworld’s situation warrants caution too. A weak stock with a sizable unlock is a classic recipe for short-term volatility. On the other hand, Sudeep Pharma and Omnitech are unlikely to see significant disruption.
Ultimately, an unlock does not automatically mean a sell-off. But when the numbers are this large, and when stocks are already trading below their issue prices, the risk is real. Investors holding these stocks should stay alert and track volume activity through the day.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post 4 Stocks Face Lock-In Expiry Today; TruAlt Bioenergy Leads With 28% Share Unlock appeared first on Trade Brains.